Mechanisms of action of antimicrobials: focus on fluoroquinolones.
about
Haemophilus parasuis: infection, immunity and enrofloxacinMechanistic and Structural Analysis of Aminoglycoside N -Acetyltransferase AAC(6′)-Ib and Its Bifunctional, Fluoroquinolone-Active AAC(6′)-Ib-cr Variant † ‡Voreloxin is an anticancer quinolone derivative that intercalates DNA and poisons topoisomerase IIInterplay in the selection of fluoroquinolone resistance and bacterial fitnessNew insights into fluoroquinolone resistance in Mycobacterium tuberculosis: functional genetic analysis of gyrA and gyrB mutationsCiprofloxacin Derivatives Affect Parasite Cell Division and Increase the Survival of Mice Infected with Toxoplasma gondiiInhibition of rat parotid and submandibular gland functions by ofloxacin, a fluoroquinolone antibiotic.Structural and functional changes by Ciprofloxacin of rat submandibular gland.Ofloxacin-like antibiotics inhibit pneumococcal cell wall-degrading virulence factors.Discovery, characterization and comparison of inhibitors of Bacillus anthracis and Staphylococcus aureus replicative DNA helicases.Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli.Assessing sensitivity to antibacterial topoisomerase II inhibitors.Quinolone resistance in Escherichia coli from Accra, Ghana.Demonstrating the Protective Efficacy of the Novel Fluoroquinolone Finafloxacin against an Inhalational Exposure to Burkholderia pseudomallei.Rapid evolution of fluoroquinolone-resistant Escherichia coli in Nigeria is temporally associated with fluoroquinolone useActivity of BMS-284756, a novel des-fluoro(6) quinolone, against Staphylococcus aureus, including contributions of mutations to quinolone resistanceRole of the water-metal ion bridge in mediating interactions between quinolones and Escherichia coli topoisomerase IV.Dual targeting of DNA gyrase and topoisomerase IV: target interactions of garenoxacin (BMS-284756, T-3811ME), a new desfluoroquinolone.Independent behavior of commensal flora for carriage of fluoroquinolone-resistant bacteria in patients at admission.Vancomycin tolerance induced by erythromycin but not by loss of vncRS, vex3, or pep27 function in Streptococcus pneumoniae.Global transcriptome and physiological responses of Acinetobacter oleivorans DR1 exposed to distinct classes of antibiotics.Structural and biochemical analysis of the pentapeptide repeat protein EfsQnr, a potent DNA gyrase inhibitorBacillus anthracis GrlAV96A topoisomerase IV, a quinolone resistance mutation that does not affect the water-metal ion bridgeBeta-lactam antibiotics induce a lethal malfunctioning of the bacterial cell wall synthesis machinery.Contribution of the 8-methoxy group to the activity of gatifloxacin against type II topoisomerases of Streptococcus pneumoniae.Topoisomerase targeting with and resistance to gemifloxacin in Staphylococcus aureusResistant pathogens in respiratory tract infections in older people.Cyclic peptide inhibitors of the β-sliding clamp in Staphylococcus aureus.Non-phenotypic tests to detect and characterize antibiotic resistance mechanisms in Enterobacteriaceae.Analysis of the gyrA gene of clinical Yersinia ruckeri isolates with reduced susceptibility to quinolones.Activity of quinolone CP-115,955 against bacterial and human type II topoisomerases is mediated by different interactions.Penetration of moxifloxacin into the human aqueous humour after oral administration.Management of community-acquired pneumonia: a focus on conversion from hospital to the ambulatory setting.Impact of fluoroquinolones on human microbiota. Focus on the emergence of antibiotic resistance.Drug interactions with Bacillus anthracis topoisomerase IV: biochemical basis for quinolone action and resistance.Failure to control an outbreak of multidrug-resistant Streptococcus pneumoniae in a long-term-care facility: emergence and ongoing transmission of a fluoroquinolone-resistant strain.Identifying mutator phenotypes among fluoroquinolone-resistant strains of Streptococcus pneumoniae using fluctuation analysis.Fluoroquinolone Resistance Mechanisms and population structure of Enterobacter cloacae non-susceptible to Ertapenem in North-Eastern France.Contributions of the combined effects of topoisomerase mutations toward fluoroquinolone resistance in Escherichia coli.A spontaneous mutation in kdsD, a biosynthesis gene for 3 Deoxy-D-manno-Octulosonic Acid, occurred in a ciprofloxacin resistant strain of Francisella tularensis and caused a high level of attenuation in murine models of tularemia.
P2860
Q26778131-A81EC735-FC4F-4AB2-8494-6F32AC2AC5E5Q27651667-8D40F5CE-108C-4128-8DE7-B63A4B8144A2Q28473683-4237D7E4-2281-40ED-A3B6-9E1D65C6DFE2Q28475870-8AADAF62-CAE6-4312-8C46-94D625AC7DE6Q28480855-E46BCE6A-232E-48CF-9540-E02D0EB2CF97Q28547065-FE21B448-335D-45EC-9D5B-09786C00E261Q30700470-BF1CD65D-9880-422D-8D17-952269318A20Q30933715-223D5F9A-BEBF-4837-A0F1-564C48905062Q33212929-EC78C4ED-30B7-4AF4-BA4F-CB739328287EQ33455209-A8693C53-DAA4-47EC-AFE9-95FA913E5998Q33534627-88C6092C-11EB-403F-B3A1-B92D9C9FF669Q33771873-0281ED38-A4CF-4082-AF83-AD977BA8388DQ33830227-36770F56-5EFE-440F-9FB9-60C31769187CQ33843665-728650C3-8661-4E6F-A664-39C70780EBC1Q34068877-A4008124-A1D3-447F-AC49-B8628B3BD8BFQ34106284-109A201B-54E0-4F7C-B3B7-0EC9880909ABQ34119765-04D6202C-C9CA-426B-BA2B-70C71235A1E7Q34142238-A22D6EF9-8F21-48C9-8535-823CD79BA8C4Q34309613-F5F83404-BAB4-44BE-96AE-F875C0FC69FBQ34321070-7262BC60-86B5-42B2-956F-ED0D606B5B66Q34362103-281BCE4F-02C0-4B97-86B1-A52D8E54D36AQ34483705-E92DBA5C-6DF4-4901-A4A2-AD966BF72D44Q34597404-889B7BB7-A470-44FC-BBDB-AAF25C3D568EQ34645039-2CDE463F-6176-4278-B7EA-725628327B42Q34721556-F4B410A4-DDED-428A-BB0E-071F22EB1221Q34725095-4783180B-2DC2-4F82-A678-D5C1F05046EEQ34744329-4FBF470C-DE2E-4D3C-BCE6-217C5D74704AQ34983899-9AE16538-AD92-4DAB-89BA-12F798377DDCQ35297743-AEE18DFE-5DD8-4341-8DEB-8F65448D013CQ35539531-D6391E3F-7F25-44EE-9410-786AC4D65AA4Q35592636-88749E10-F288-4085-AAB8-43D1DB118993Q35593192-C4D7BFDC-0DD5-4C08-A2AF-769B09010E99Q35627633-77B3A338-8AFF-467C-A2D1-74392E27E02FQ35676675-8EA1601F-5C91-49FC-A535-562158CD577CQ35682250-1F3803B8-05E3-4947-A567-EE087F158924Q36082806-2DF23861-AFEF-44E4-AF0E-2C43D462773BQ36094891-5E19453C-B486-4C1A-B57E-B4303DF3A7C4Q36196200-776952A2-B505-40BE-91CC-6AB032545BBFQ36295431-1DEFCDA6-D8C9-4861-AFC4-EBAD7BEA5D07Q36318241-53940C2D-114C-4DE6-9E6D-63CA90BEE472
P2860
Mechanisms of action of antimicrobials: focus on fluoroquinolones.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Mechanisms of action of antimicrobials: focus on fluoroquinolones.
@ast
Mechanisms of action of antimicrobials: focus on fluoroquinolones.
@en
Mechanisms of action of antimicrobials: focus on fluoroquinolones.
@nl
type
label
Mechanisms of action of antimicrobials: focus on fluoroquinolones.
@ast
Mechanisms of action of antimicrobials: focus on fluoroquinolones.
@en
Mechanisms of action of antimicrobials: focus on fluoroquinolones.
@nl
prefLabel
Mechanisms of action of antimicrobials: focus on fluoroquinolones.
@ast
Mechanisms of action of antimicrobials: focus on fluoroquinolones.
@en
Mechanisms of action of antimicrobials: focus on fluoroquinolones.
@nl
P356
P1476
Mechanisms of action of antimicrobials: focus on fluoroquinolones.
@en
P2093
P304
P356
10.1086/319370
P407
P478
32 Suppl 1
P577
2001-03-01T00:00:00Z